It’s time to rethink clinical trial protocols, and ensure inclusive designs through democratising our health data, in a privacy preserving way

What’s Inside?

Throughout my career in the pharmaceutical industry managing clinical trials and study programs, I have been confronted with the same recurring problems. Trials struggle to recruit and retain enough patients, they fail to meet target timelines and the vast majority don’t conclude on time.

This blog covers why it is important to:

• Capture the patient experience.
• Bring in treating physicians
• Include natural history studies
• Look to the data